Paper39725830
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies.
Alam M and 7 others. Mol Biomed, 2024. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Papers, record 39725830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39725830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catechin | Major topic |
| Humans | |
| Antioxidants | |
| Neuroprotective Agents | |
| Neoplasms | |
| Signal Transduction | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant No. 3-69/2020- CCRUM/Tech | Ministry of AYUSH, Government of India | PubMed |
Source PubMed
References182
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26992034 | The green tea polyphenol EGCG inhibits E. coli biofilm formation by impairing amyloid curli fibre assembly and downregulating the biofilm regulator CsgD via the σ(E) -dependent sRNA RybB. | Mol Microbiol | 2016 | https://conductscience.org/library/papers/26992034 | PubMed |
| 2 | 29480368 | The Global Epidemic of the Metabolic Syndrome. | Curr Hypertens Rep | 2018 | https://conductscience.org/library/papers/29480368 | PubMed |
| 3 | 37446908 | Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. | Molecules | 2023 | https://conductscience.org/library/papers/37446908 | PubMed |
| 4 | 27576948 | A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67kDa Laminin Receptor (LR). | Int J Biol Macromol | 2016 | https://conductscience.org/library/papers/27576948 | PubMed |
| 5 | 31298934 | Antimetastatic Properties of Tea Polyphenols. | Nutr Cancer | 2020 | https://conductscience.org/library/papers/31298934 | PubMed |
| 6 | 37445915 | The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445915 | PubMed |
| 7 | 33494273 | Inhibition of Biofilm Formation by the Synergistic Action of EGCG-S and Antibiotics. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33494273 | PubMed |
| 8 | 29783725 | Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies. | Nutrients | 2018 | https://conductscience.org/library/papers/29783725 | PubMed |
| 9 | 38507840 | Epigallocatechin-3-gallate-induced tolerance to cadmium stress involves increased flavonoid synthesis and nutrient homeostasis in tomato roots. | Plant Physiol Biochem | 2024 | https://conductscience.org/library/papers/38507840 | PubMed |
| 10 | 36948143 | Therapeutic application of natural products: NAD+ metabolism as potential target. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36948143 | PubMed |
| 11 | 31665823 | Translating In Vitro Acrolein-Trapping Capacities of Tea Polyphenol and Soy Genistein to In Vivo Situation is Mediated by the Bioavailability and Biotransformation of Individual Polyphenols. | Mol Nutr Food Res | 2020 | https://conductscience.org/library/papers/31665823 | PubMed |
| 12 | 9810958 | Genetic and environmental risk factors for Parkinson's disease in a Chinese population. | J Neurol Neurosurg Psychiatry | 1998 | https://conductscience.org/library/papers/9810958 | PubMed |
| 13 | 36212989 | Effects of green tea extract epigallocatechin-3-gallate (EGCG) on oral disease-associated microbes: a review. | J Oral Microbiol | 2022 | https://conductscience.org/library/papers/36212989 | PubMed |
| 14 | 27268025 | Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). | Nutr J | 2016 | https://conductscience.org/library/papers/27268025 | PubMed |
| 15 | 33525629 | The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33525629 | PubMed |
| 16 | 34051305 | The synergistic protection of EGCG and quercetin against streptozotocin (STZ)-induced NIT-1 pancreatic β cell damage via upregulation of BCL-2 expression by miR-16-5p. | J Nutr Biochem | 2021 | https://conductscience.org/library/papers/34051305 | PubMed |
| 17 | 29219149 | Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/29219149 | PubMed |
| 18 | 30876953 | Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. | J Control Release | 2019 | https://conductscience.org/library/papers/30876953 | PubMed |
| 19 | 19844590 | Antimicrobial properties of green tea catechins. | Food Sci Technol Bull | 2005 | https://conductscience.org/library/papers/19844590 | PubMed |
| 20 | 36009285 | Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases? | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36009285 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794106 | Development of Epigallocatechin-Loaded Water Caltrop Starch Aerogels: Structure, Functional Properties and In Vitro Release Behavior. | Foods | 2026 | https://conductscience.org/library/papers/42794106 | PubMed |
| 42701648 | Binding of epigallocatechin-3-gallate to myoglobin attenuated hemin release and lipid peroxidation: New insight into the antioxidant mechanism. | Curr Res Food Sci | 2026 | https://conductscience.org/library/papers/42701648 | PubMed |
| 42650188 | Transcriptomic Analysis Reveals the Antioxidant and Anti-Inflammatory Mechanisms of EGCG-Zn Nanoparticles in Dextran Sulfate Sodium-Induced Colitis in Mice. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42650188 | PubMed |
| 42627559 | EGCG targeting autophagy in cardiovascular diseases: mechanisms and therapeutic potential. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42627559 | PubMed |
| 42621019 | Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42621019 | PubMed |
| 42587788 | Extracellular Aβ42 Oligomers Induce ROCK2 Hyperactivation Through Dual Mediation by RhoA and GzmB: Significance of Moderate ROCK2 Activity in Neural Cells. | Cells | 2026 | https://conductscience.org/library/papers/42587788 | PubMed |
| 42510599 | Computational Study of the Peroxyl Radical Scavenging Ability of Phenolic Antioxidants. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42510599 | PubMed |
| 42506452 | Molecular Mechanisms Associated with Metabolic Dysfunction: Contributions of Nutritional Genomics. | Metabolites | 2026 | https://conductscience.org/library/papers/42506452 | PubMed |
| 42451748 | Enzymatic Fructosylation of EGCG Significantly Enhances Its Stability for Skin Barrier Repair and Anti-Aging Activities. | Molecules | 2026 | https://conductscience.org/library/papers/42451748 | PubMed |
| 42403542 | EGCG-Building Nanocarriers for Multitasking Drug Delivery: Design Principles, Therapeutic Opportunities, and Translational Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42403542 | PubMed |
| 42387586 | Exploring the role of the NLRP3 Inflammasome in polycystic ovary syndrome: therapeutic potential of herbal medicines. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/42387586 | PubMed |
| 42359071 | Chemoprophylaxis effect of EGCG on various digestive system diseases: a systematic review and meta-analysis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42359071 | PubMed |
| 42298579 | The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42298579 | PubMed |
| 42243131 | Green tea catechin EGCG attenuates hippocampal atrophy and cognitive impairment in obesity via autophagy signaling. | NPJ Sci Food | 2026 | https://conductscience.org/library/papers/42243131 | PubMed |
| 42182534 | Green tea (Camellia sinensis (L.) Kuntze) nanoemulgel promotes buccal mucosal ulcer repair. | J Taibah Univ Med Sci | 2026 | https://conductscience.org/library/papers/42182534 | PubMed |
| 42125220 | Formulation Progress, Challenges, and Perspectives of Anti-Inflammatory Natural Products. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42125220 | PubMed |
| 42122795 | Biochemical Profiles, Mineral Accumulation, and Water-Soluble Fluoride Traits of 65 Tea (Camellia sinensis) Cultivars: For Germplasm Screening and Quality Evaluation. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42122795 | PubMed |
| 42122230 | Rethinking Advanced Renal Cell Carcinoma: Integrative Genomics, Immunotherapy, and Molecular-Orthomolecular Strategies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122230 | PubMed |
| 42121858 | A Novel circRERE/miR-27a-3p/Caspase9 Signaling Axis Promotes Cardiomyocyte Apoptosis in Ischemic Myocardium: Insights from Epigallocatechin Gallate-Primed Exosomes. | Cells | 2026 | https://conductscience.org/library/papers/42121858 | PubMed |
| 42118233 | Orchestrated Engineered Polyphenol-Peptide Condensates Coupled With β-GP Reverses Diabetic Osteoporosis by Remodeling Mitophagy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42118233 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39725830
GET https://conductscience.org/api/papers/v1/39725830/references?page=2